Caredx Inc sell Biotechhunter
Summary
This prediction ended on 07.09.20 with a price of €26.64. With a performance of -6.10%, the SELL prediction by Biotechhunter was trending in the right direction. Biotechhunter has 50% into this predictionCareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Caredx Inc | -2.520% | -2.520% | -14.175% | 63.591% |
| iShares Core DAX® | -0,68 % | -4,85 % | 1,94 % | 54,33 % |
| iShares Nasdaq 100 | -0,03 % | 2,86 % | 18,90 % | 82,62 % |
| iShares Nikkei 225® | -0,54 % | -5,02 % | 28,15 % | 55,64 % |
| iShares S&P 500 | -0,21 % | 0,92 % | 13,69 % | 61,21 % |
Comments by Biotechhunter for this prediction
In the thread Caredx Inc diskutieren
In the thread Trading Caredx Inc


